TickerLeague.com
Insmed Incorporated logo

Insmed

INSM

Healthcare
NASDAQ
US
CIK:0001104506

About Insmed

Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination an…

Power Profile

Revenue Counter

Insmed earns $19.23/sec (TTM: $606.42M)

Revenue counter

Earnings Counter

Insmed loses −$40.49/sec (TTM: −$1.28B)

Earnings counter

Economic Scale

Insmed revenue exceeds Micronesia, Fed. Sts. GDP ($471.4M)

Economic scale

What If Invested

See what $1,000 invested in Insmed would be worth today

What if invested

How it makes money

Visual revenue breakdown: how Insmed generates income and where it flows

How it makes money

Seasonality

Monthly and quarterly returns heatmap, seasonality matrix for Insmed

View seasonality
Q1 2026
Report Date
May 7, 2026
BMO
Lock in
50 days 4 hours
Revenue
Analyst Forecast
$300.91M
EPS
Analyst Forecast
-1.01